Friday 6 November 2026
Export QDEL’s income statement to Excel — free account
QuidelOrtho Corporation
QDEL Healthcare Medical Devices
QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +92.7%
- Free cash flow
- +120.7%
- Total debt
- +10.5%
Quarter to September 2026, against a year earlier
10.73
2.11
−16.43%
Follow QDEL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 4 | 3 | 4 |
| (46.15%) | (49.95%) | (45.91%) | (19.29%) | ||
| (18.56%) | (20.03%) | (17.34%) | (6.45%) | ||
ROIC |
(13.05%) | (13.97%) | (11.35%) | (1.75%) | |
Return on Tangible Assets |
(61.53%) | (69.04%) | (60.89%) | (21.69%) | |
Average Days of Receivables |
55.75 | 49.44 | 48.04 | 52.85 | |
Free Cash Flow per Share |
(1.22) | (2.34) | (3.09) | (1.72) | |
Free Cash Flow |
(83.00) | (159.40) | (211.20) | (117.90) | |
Capital Expenditures |
(188.20) | (166.00) | (154.00) | (125.80) | |
| Other line items | |||||
Cash ROIC |
(1.75%) | (3.41%) | (4.41%) | (2.41%) | |
Accounts Receivable Turnover |
7.81 | 8.23 | 8.53 | 6.81 | |
Accounts Payable Turnover |
5.54 | 6.17 | 6.51 | 6.19 | |
Inventory Turnover |
2.62 | 2.49 | 2.47 | 2.30 | |
Average Days of Payables |
70.04 | 60.77 | 58.27 | 63.92 | |
Days of Inventory on Hand |
144.80 | 152.61 | 152.48 | 162.17 | |
Tax Rate |
0.02 | 0.03 | 0.02 | 0.10 | |
Research and Development Expense of Revenue |
6.82% | 6.70% | 6.76% | 7.01% | |
Selling, General and Administrative Expense of Revenue |
27.33% | 28.55% | 28.80% | 29.54% | |
Share Based Compensation of Revenue |
1.68% | 1.69% | 1.65% | 1.75% | |
Interest Coverage |
(5.18) | (5.21) | (4.06) | (0.60) | |
Operating CF/Net income |
(0.09) | (0.01) | 0.05 | (0.02) | |
Depreciation/Fixed assets |
0.84 | 0.86 | 0.87 | 0.00 | |
Capex/Depreciation |
(0.16) | (0.14) | (0.13) | 0.00 | |
Revenue per Share |
40.27 | 38.96 | 39.15 | 37.75 | |
Operating CF per Share |
1.55 | 0.10 | (0.84) | 0.12 | |
Capex per Share |
(2.78) | (2.43) | (2.25) | (1.83) | |
Capex to Sales |
0.07 | 0.06 | 0.06 | 0.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026